Mapping the Journey* * Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 47, Issue 8, 2006, Pages 1612-1614

  Stevenson, Lynne Warner ^a   Lewis, Eldrin ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; METOPROLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

CLINICAL TRIAL; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG COST; EDITORIAL; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SURVIVAL; TREATMENT OUTCOME; FORWARD HEART FAILURE; MORTALITY; NOTE; PATHOPHYSIOLOGY; QUALITY OF LIFE;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CARDIAC OUTPUT, LOW; HUMANS; METOPROLOL; PROPANOLAMINES; QUALITY OF LIFE;

EID: 33646055792     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.054     Document Type: Editorial

References (18)

1. World of Quotes. Available at: http://www.worldofquotes.com/author/Robert-Louis-Stevenson/1/index.html. Accessed February 21, 2006.
2. Cleland J.G.F., Charlesworth A., Lubsen J., et al., COMET Investigators. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure. a report from the Carvedilol or Metoprolol European Trial (COMET). J Am Coll Cardiol 47 (2006) 1603-1611
3. Poole-Wilson P.A., Swedberg K., Cleland J.G., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET). randomised controlled trial. Lancet 362 (2003) 7-13
4. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
5. Rose E.A., Gellijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
6. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
7. Rector T.S. A conceptual model of quality of life in relation to heart failure. J Card Fail 11 (2005) 173-176
8. Berry C., and McMurray J. A review of quality of life evaluations in patients with congestive heart failure. Pharmacoeconomics 15 (1999) 247-271
9. Torrance G.W. Utility approach to measuring health-related quality of life. J Chron Dis 40 (1987) 593-603
10. Lewis E.F., Johnson P.A., Johnson W., et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 20 (2001) 1016-1024
11. Stevenson L., Hellkamp A., Leier C.V., et al. Beyond body counts to days of patient-preferred survival with advanced heart failure. an analysis from the ESCAPE trial. (abstr). Circulation 112 (2005) II640
12. ESCAPE Investigators and Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization. JAMA 294 (2005) 1625-1633
13. Shah M.R., O'Connor C.M., Sopko G., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE). design and rationale. Am Heart J 141 (2001) 528-535
14. Moskowitz A.J., Weinberg A.D., Oz M.C., and Williams D.L. Quality of life with an implanted left ventricular assist device. Ann Thorac Surg 64 (1997) 1764-1769
15. Stevenson L.W. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Circulation 108 (2003) 492-497
16. Gaziano T. Cardiovascular disease in the developing world and its cost-effective management. Circulation 112 (2005) 3547-3553
17. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). a randomised trial. Lancet 353 (1999) 9-13
18. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007